In-Depth Notes on Cardiovascular Pharmacology Audio

  • Cardiovascular Pharmacology Overview

    • Understanding basic concepts of preload and afterload is crucial for pharmacology in cardiovascular health.
  • Definitions:

    • Preload: Amount of blood in ventricles during diastole (heart relaxation).
    • Afterload: Resistance the ventricles must overcome to eject blood during systole (heart contraction).
  • Factors Affecting Preload:

    • Increased by fluid retention (can lead to heart failure).
    • Decreased preload can occur with blood loss or dehydration.
  • Factors Affecting Afterload:

    • Influenced by factors like high blood pressure and narrowed blood vessels.
    • Medications may target either fluid retention (preload) or resistance (afterload).
  • Drug Classes for Heart Failure:

    • Importance of pharmacology in exam and practice.
  • Digoxin:

    • Once a first-line treatment for heart failure; still used but with caution.
    • Derived from foxglove plant; can cause toxicity.
    • Mechanism: Increases cardiac output but slows heart rate, allowing more filling time.
    • Administration Reminder: Check apical pulse; hold if below 60 bpm.
    • Toxicity Signs:
    • Bradycardia, visual disturbances (green/yellow halos), GI upset.
    • Importance of monitoring electrolytes (potassium, calcium) to avoid toxicity.
  • Management of Digoxin Toxicity:

    • Hold the medication and monitor for arrhythmias.
    • Treatments include Digibind, atropine, and potentially cardioversion.
  • ACE Inhibitors:

    • First-line treatment for hypertension and heart failure (e.g., lisinopril).
    • Decrease afterload by causing vasodilation.
    • Common side effects include cough, angioedema, and hyperkalemia.
  • Diuretics:

    • Used to manage fluid overload in heart failure by decreasing preload.
    • Types include:
      • Loop Diuretics (e.g., furosemide): Watch for electrolyte imbalances (especially potassium).
      • Thiazide Diuretics: Monitor sodium and potassium levels, can cause dehydration.
      • Potassium-Sparing: Spironolactone, holds onto potassium but may lead to hyperkalemia.
  • Beta Blockers:

    • Lower heart rate and decrease contractility; used for hypertension and heart rate control.
    • Be cautious with abrupt withdrawals, and monitor heart rate and blood pressure before administration.
  • Calcium Channel Blockers:

    • Effective for vasodilation; can help manage fast heart rates but are not first-line for heart failure.
  • Thrombolytics:

    • Used in acute care for stroke management (e.g., TPA); high risk for bleeding.
    • Monitor for signs of bleeding and complete a thorough neuro assessment.
  • Anticoagulants:

    • Variants include heparin (short-term) and warfarin (long-term).
    • Essential to monitor PTT for heparin and INR for warfarin.
  • Patient Education:

    • Regular lab work for monitoring drug efficacy and toxicity, especially for digoxin and anticoagulants.
    • Advise on recognizing signs of adverse effects for each medication.
    • Avoid abrupt changes in medications without consulting healthcare providers.
  • Conclusion:

    • A thorough understanding of these pharmacologic agents, their mechanisms, and side effects is critical for effective patient management in cardiovascular health.